Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey S Borer

Showing results (1-10 of 186) with videos related to

Pageof 19
Sort By:
Journal of the American College of Cardiology|November 19, 2016
Aortic Valve Surgery for Aortic Regurgitation: The Threshold Is FallingJeffrey S Borer
Circulation|November 20, 2002
Aortic valve replacement for the asymptomatic patient with aortic regurgitation: a new piece of the strategic puzzleJeffrey S Borer
Drugs|December 6, 2007
If inhibition by Ivabradine. ForewordJeffrey S Borer
Journal of the American College of Cardiology|July 21, 2004
Left ventricular hypertrophy in hypertrophic cardiomyopathy: what's in a phenotype?Jeffrey S Borer
JACC. Cardiovascular Imaging|April 10, 2009
Management decisions in aortic regurgitation: has the time for exercise assessment finally arrived?Jeffrey S Borer
Cardiology|December 14, 2012
Statement on matching language to the type of evidence used in describing outcomes dataJeffrey S Borer,
Arteriosclerosis, Thrombosis, and Vascular Biology|February 26, 2005
Aortic stenosis and statins: more evidence of "pleotropy"?Jeffrey S Borer
Journal of the American College of Cardiology|April 20, 2019
Application of Transcatheter Repair to Tricuspid Regurgitation: Still Looking Through a Dark GlassJeffrey S Borer
Journal of the American College of Cardiology|December 21, 2004
Development of cardiovascular drugs: the U.S. regulatory milieu from the perspective of a participating nonregulatorJeffrey S Borer
Nature Clinical Practice. Cardiovascular Medicine|November 3, 2005
Drug insight: If inhibitors as specific heart-rate-reducing agentsJeffrey S Borer
Pageof 19

Showing results (1-10 of 186) with videos related to

Sort By:
Pageof 19
Journal of the American College of Cardiology|November 19, 2016
Aortic Valve Surgery for Aortic Regurgitation: The Threshold Is FallingJeffrey S Borer
Circulation|November 20, 2002
Aortic valve replacement for the asymptomatic patient with aortic regurgitation: a new piece of the strategic puzzleJeffrey S Borer
Drugs|December 6, 2007
If inhibition by Ivabradine. ForewordJeffrey S Borer
Journal of the American College of Cardiology|July 21, 2004
Left ventricular hypertrophy in hypertrophic cardiomyopathy: what's in a phenotype?Jeffrey S Borer
JACC. Cardiovascular Imaging|April 10, 2009
Management decisions in aortic regurgitation: has the time for exercise assessment finally arrived?Jeffrey S Borer
Cardiology|December 14, 2012
Statement on matching language to the type of evidence used in describing outcomes dataJeffrey S Borer,
Arteriosclerosis, Thrombosis, and Vascular Biology|February 26, 2005
Aortic stenosis and statins: more evidence of "pleotropy"?Jeffrey S Borer
Journal of the American College of Cardiology|April 20, 2019
Application of Transcatheter Repair to Tricuspid Regurgitation: Still Looking Through a Dark GlassJeffrey S Borer
Journal of the American College of Cardiology|December 21, 2004
Development of cardiovascular drugs: the U.S. regulatory milieu from the perspective of a participating nonregulatorJeffrey S Borer
Nature Clinical Practice. Cardiovascular Medicine|November 3, 2005
Drug insight: If inhibitors as specific heart-rate-reducing agentsJeffrey S Borer
Pageof 19